These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

572 related items for PubMed ID: 14695218

  • 1. MICA/NKG2D-mediated immunogene therapy of experimental gliomas.
    Friese MA, Platten M, Lutz SZ, Naumann U, Aulwurm S, Bischof F, Bühring HJ, Dichgans J, Rammensee HG, Steinle A, Weller M.
    Cancer Res; 2003 Dec 15; 63(24):8996-9006. PubMed ID: 14695218
    [Abstract] [Full Text] [Related]

  • 2. TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells.
    Eisele G, Wischhusen J, Mittelbronn M, Meyermann R, Waldhauer I, Steinle A, Weller M, Friese MA.
    Brain; 2006 Sep 15; 129(Pt 9):2416-25. PubMed ID: 16891318
    [Abstract] [Full Text] [Related]

  • 3. RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo.
    Friese MA, Wischhusen J, Wick W, Weiler M, Eisele G, Steinle A, Weller M.
    Cancer Res; 2004 Oct 15; 64(20):7596-603. PubMed ID: 15492287
    [Abstract] [Full Text] [Related]

  • 4. Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate.
    Armeanu S, Bitzer M, Lauer UM, Venturelli S, Pathil A, Krusch M, Kaiser S, Jobst J, Smirnow I, Wagner A, Steinle A, Salih HR.
    Cancer Res; 2005 Jul 15; 65(14):6321-9. PubMed ID: 16024634
    [Abstract] [Full Text] [Related]

  • 5. Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity.
    Pende D, Rivera P, Marcenaro S, Chang CC, Biassoni R, Conte R, Kubin M, Cosman D, Ferrone S, Moretta L, Moretta A.
    Cancer Res; 2002 Nov 01; 62(21):6178-86. PubMed ID: 12414645
    [Abstract] [Full Text] [Related]

  • 6. Attenuation of the glucocorticoid response during Ad5IL-12 adenovirus vector treatment enhances natural killer cell-mediated killing of MHC class I-negative LNCaP prostate tumors.
    Raja Gabaglia C, Diaz de Durana Y, Graham FL, Gauldie J, Sercarz EE, Braciak TA.
    Cancer Res; 2007 Mar 01; 67(5):2290-7. PubMed ID: 17332360
    [Abstract] [Full Text] [Related]

  • 7. MICA antigens stimulate T cell proliferation and cell-mediated cytotoxicity.
    Zhang Y, Stastny P.
    Hum Immunol; 2006 Mar 01; 67(3):215-22. PubMed ID: 16698445
    [Abstract] [Full Text] [Related]

  • 8. Generation of antitumor responses by genetic modification of primary human T cells with a chimeric NKG2D receptor.
    Zhang T, Barber A, Sentman CL.
    Cancer Res; 2006 Jun 01; 66(11):5927-33. PubMed ID: 16740733
    [Abstract] [Full Text] [Related]

  • 9. NKG2D engagement of colorectal cancer-specific T cells strengthens TCR-mediated antigen stimulation and elicits TCR independent anti-tumor activity.
    Maccalli C, Pende D, Castelli C, Mingari MC, Robbins PF, Parmiani G.
    Eur J Immunol; 2003 Jul 01; 33(7):2033-43. PubMed ID: 12884870
    [Abstract] [Full Text] [Related]

  • 10. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity.
    Diefenbach A, Hsia JK, Hsiung MY, Raulet DH.
    Eur J Immunol; 2003 Feb 01; 33(2):381-91. PubMed ID: 12645935
    [Abstract] [Full Text] [Related]

  • 11. The combination of ionizing radiation and peripheral vaccination produces long-term survival of mice bearing established invasive GL261 gliomas.
    Newcomb EW, Demaria S, Lukyanov Y, Shao Y, Schnee T, Kawashima N, Lan L, Dewyngaert JK, Zagzag D, McBride WH, Formenti SC.
    Clin Cancer Res; 2006 Aug 01; 12(15):4730-7. PubMed ID: 16899624
    [Abstract] [Full Text] [Related]

  • 12. CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions.
    Allez M, Tieng V, Nakazawa A, Treton X, Pacault V, Dulphy N, Caillat-Zucman S, Paul P, Gornet JM, Douay C, Ravet S, Tamouza R, Charron D, Lémann M, Mayer L, Toubert A.
    Gastroenterology; 2007 Jun 01; 132(7):2346-58. PubMed ID: 17570210
    [Abstract] [Full Text] [Related]

  • 13. Expression of the NKG2D ligand UL16 binding protein-1 (ULBP-1) on dendritic cells.
    Schrama D, Terheyden P, Otto K, Kämmerer U, Bröcker EB, Lühder F, Cosman D, Andersen MH, Becker JC.
    Eur J Immunol; 2006 Jan 01; 36(1):65-72. PubMed ID: 16342232
    [Abstract] [Full Text] [Related]

  • 14. Chimeric NKG2D receptor-bearing T cells as immunotherapy for ovarian cancer.
    Barber A, Zhang T, DeMars LR, Conejo-Garcia J, Roby KF, Sentman CL.
    Cancer Res; 2007 May 15; 67(10):5003-8. PubMed ID: 17510432
    [Abstract] [Full Text] [Related]

  • 15. Cell surface organization of stress-inducible proteins ULBP and MICA that stimulate human NK cells and T cells via NKG2D.
    Eleme K, Taner SB, Onfelt B, Collinson LM, McCann FE, Chalupny NJ, Cosman D, Hopkins C, Magee AI, Davis DM.
    J Exp Med; 2004 Apr 05; 199(7):1005-10. PubMed ID: 15051759
    [Abstract] [Full Text] [Related]

  • 16. NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation.
    Gilfillan S, Ho EL, Cella M, Yokoyama WM, Colonna M.
    Nat Immunol; 2002 Dec 05; 3(12):1150-5. PubMed ID: 12426564
    [Abstract] [Full Text] [Related]

  • 17. Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression.
    Song H, Kim J, Cosman D, Choi I.
    Cell Immunol; 2006 Jan 05; 239(1):22-30. PubMed ID: 16630603
    [Abstract] [Full Text] [Related]

  • 18. Release of MICB molecules by tumor cells: mechanism and soluble MICB in sera of cancer patients.
    Salih HR, Goehlsdorf D, Steinle A.
    Hum Immunol; 2006 Mar 05; 67(3):188-95. PubMed ID: 16698441
    [Abstract] [Full Text] [Related]

  • 19. Down-regulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142.
    Chalupny NJ, Rein-Weston A, Dosch S, Cosman D.
    Biochem Biophys Res Commun; 2006 Jul 21; 346(1):175-81. PubMed ID: 16750166
    [Abstract] [Full Text] [Related]

  • 20. Expression of major histocompatibility complex class I chain-related molecule A, NKG2D, and transforming growth factor-beta in the liver of humans with alveolar echinococcosis: new actors in the tolerance to parasites?
    Zhang S, Hüe S, Sène D, Penfornis A, Bresson-Hadni S, Kantelip B, Caillat-Zucman S, Vuitton DA.
    J Infect Dis; 2008 May 01; 197(9):1341-9. PubMed ID: 18422447
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.